ENLYTE
Live / Registered — Registered and renewed (as of 04 Nov 2022)
What this means for you
Registered since 19 Mar 2013. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 19 Mar 2023).
Record
- Serial number
- 85354622
- Registration number
- 4305928
- Mark type
- Stylized text
- Filed
- 23 Jun 2011
- Published for opposition
- 29 May 2012
- Registered
- 19 Mar 2013
- Next maintenance due
- 19 Mar 2023
- Attorney of record
- Greg Mier
Goods and services
- Class 005 — Pharmaceuticals: Prescription nutraceuticals for the treatment of low folate levels
Owner
- JayMac Pharmaceuticals, LLC., Sunset, LA, US
- JayMac Pharmaceuticals, LLC., Sunset, LA, US
- JayMac Pharmaceuticals, LLC., Sunset, LA, US
Prosecution history
- 04 Nov 2022 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 04 Nov 2022 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 04 Nov 2022 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 03 Nov 2022 — TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
- 14 Sept 2022 — POST REGISTRATION ACTION MAILED - SEC. 8 & 9
- 14 Sept 2022 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 21 Mar 2022 — TEAS SECTION 8 & 9 RECEIVED
- 19 Mar 2022 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 07 Feb 2019 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 07 Feb 2019 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 07 Feb 2019 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 09 Jan 2019 — TEAS SECTION 8 & 15 RECEIVED
- 19 Mar 2018 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 19 Mar 2013 — REGISTERED-PRINCIPAL REGISTER
- 13 Feb 2013 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED